Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5774_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
57 Мб
Скачать
ab
7 Interventional Ultrasound inObstetrics andGynecology
305
a
b
c
Fig. 7.13 Sonohysterography of multiple endometrial polyps com­bined with incomplete uterus septum. (a) The patient is 27years old, who was diagnosed with primary infertility. The manifestation of ultra­sound shows two separate uterine cavities, with thickened and inhomo­geneous endometrium. (b) The transverse view of the uterus shows two
uterine cavities. (c) After injection of contrast agent, the right uterine cavity is observed to be separated by 1.0cm, and left uterine cavity separated by 1.1cm. Several slightly hyperechoic masses are found on each wall in each uterine cavity. The shape is smooth, the boundary is clear, the maximum diameter of the mass is 1.5cm
Fig. 7.14 Sonohysterography of submucosal uterine myoma (I). (a) The patient is 60 years old. Sonogram shows the slightly hypoechoic occupation in the uterine cavity, with unclear boundary.
(b) After the injec tion of contrast agents, the hypoechoic mass in the size of 2.2 cm × 1.7 cm × 1.5 cm is attached to the posterior wall of the uterine cavity. And the width of attachment surface is 1.5 cm
306
ab
H. Luo et al.
Fig. 7.15 Sonohysterography of submucosal uterine myoma (II). (a) The patient is 45years old and has a history of menorrhagia with blood clots. Sonogram shows the slightly hypoechoic mass in the uterine cav­ity with the diameter of about 3cm. (b) After the injection of contrast
a
c
agents, the hypoechoic mass in the size of 2.7cm×2.5cm×1.7cm is attached to the anterior wall of the uterine cavity, with inner attenuation
b
Fig. 7.16 Sonohysterography of intramural uterine myoma extruding to the cavity. (a) The patient is 34 years old, and the sonogram shows the occupation in the uterine cavity. (b) After injection of the contrast agent, the hypoechoic mass in the uterine cavity is attached to the right
anterior wall, near the fundus; (c). About two-third of the mass is pro­truding into the uterine cavity, and one-third is located in the muscle wall
ab
7 Interventional Ultrasound inObstetrics andGynecology
307
– Obstructed fallopian tube: When injecting the con-
trast agent, the resistance is large, and the reux will happen when the injection stops. The fallo­pian tube is absent or partially displayed. There is no strong echo around the ovary and no microbub­ble echoes in the pelvic cavity (Fig.7.28)
– The fallopian tube is partially obstructed: There is
resistance when injecting contrast agents and a small amount of reux. The fallopian tube is locally slender or nodular, and runs in the tortuous and angled way. There is half a circle of strong echo around the ovaries and a small amount of microbubble in the rectouterine pouch and intesti­nal space (Fig. 7.29).
UT
Fig. 7.17 Endometrial atrophy. Sonohysterography shows the thin endometrium, only 1mm in thickness
• patency assessment of the fallopian tube (negative contrast agent),
– The fallopian tube is unobstructed: After injection,
the contrast agent quickly ows out from the bilat­eral fallopian tubes, and the ultrasonography shows a hyperechoic band around adnexa. Liquid display in the rectouterine pouch and there is no resistance during injection (Fig.7.30).
– Obstructed fallopian tube: After injection of con-
trast medium, the contrast medium forms a vor­tex at the corner of the uterus, and no contrast medium passes through the fallopian tube. There is no band-like hyperechoic ow seen in the adnexa area, and no obvious liquid dark area in the rectouterine pouch. The resistance is high, and the patient feels abdominal pain or bloating. In hydrosalpinx cases, the injected contrast agent ows in the dilated fallopian tube (Fig.7.31).
– The fallopian tube is partially obstructed: After
the contrast medium is injected, the contrast medium slowly passes through the fallopian tube, and there is no obvious banding hyper­echoic ow around the adnexa, and a little liq­uid in the rectouterine pouch. When injecting, resistance can be felt.
IV. Intraoperative monitoring during intrauterine surgery.
With the extensive development of uterine cavity sur-
gery, complications have also increased. Application of ultrasonography as intraoperative monitoring can help to ensure the safety of surgery and reduce the occurrence of complications. In the past three years, 676 cases of vari­ous difcult transvaginal operations have been con-
Fig. 7.18 Sonohysterography of endometrial hyperplasia (I). (a) The patient is 40years old, and occupation lesion is suspected in the uterine cavity. (b) After injecting the contrast agent, sonogram shows the endo-
metrium is uneven, and the posterior wall is locally thickened by
1.0cm, with a range of 1.9 cm×1.6 cm, which is homogeneous and clearly demarcated from the myometrium
308
H. Luo et al.
a
b
c
Fig. 7.19 Sonohysterography of endometrial hyperplasia (II). (a) The patient is 36years old and has a history of menorrhagia for 6months. The endometrium is thickened and inhomogeneous. (b) After injection
ducted by the monitor of ultrasonography, in our hospital with a success rate of 97.7%, no serious complications occurred. Ultrasonography has been used as a routine monitoring technique in intrauterine surgery.
• Indications – Difcult uterine cavity surgery, such as abnormal
uterine position, uterine malformation, abnormal pregnancy, and various kinds of uterine cavity sur­gery that need to be performed again after failure.
– Hysteroscopy surgery.
• Operation process
The transabdominal approach is often chosen as
ultrasound monitoring for intrauterine surgery.
– Require the patient to properly ll the bladder
before surgery. The patient took the bladder lithotomy position, routinely get disinfected and draped.
of contrast agents, the thickness of the posterior endometrium is 1.1cm. (c) Sonogram shows the irregular surface of the endometrium after injection of contrast agent
– Ultrasound monitoring is processed in the longitu-
dinal section. Before surgery, observe the position of the uterus, intrauterine gestational sac, villi attachment, and the relationship between occupa­tion disease, uterine cavity, and muscle wall.
– During the operation, the probe moving up and
down, guiding the surgical equipment, and ensures the operation of equipment is within the track.
– Observe whether there is an abnormal situation in
the pelvis cavity after the operation.
• Notes – Pay attention to prevent the occurrence of uterine
injury and perforation, track the position of the device, and constantly inform the surgeon of the direction and location of the device.
– Intraoperative ultrasound images show that the
operating instruments are strongly echoed with
7 Interventional Ultrasound inObstetrics andGynecology
309
a
b
c
Fig. 7.20 Sonohysterography of endometrial hyperplasia (III). (a) The patient is 29years old, and occupational disease is suspected in the uter­ine cavity. (b) After injection of contrast agent, the thickness of the endometrium is uneven. The endometrial thickness of the anterior wall
metallic shadows and pay attention to identify arti­facts (Fig.7.32).
V. Contrast-enhanced ultrasonography
Contrast-enhanced ultrasonography (CEUS) is nonin­vasive functional imaging of blood perfusion. Ultrasound contrast microbubbles enter the blood circulation after injected into the peripheral vein, and the microbubbles form nonlinear signals in the sound eld under the action of ultrasound. Due to the weak signals of the surrounding tissues and blood, and the signal to noise is improved by ultrasound contrast imaging technology, the visualization of blood perfusion in microcirculation has been greatly improved. Contrast microbubbles can ow and distribute along with the blood system throughout the body. It is an excellent blood imaging agent. CEUS is now used in many clinical disciplines.
is 0.3cm, whereas that of the posterior uterine wall is 0.8cm. (c) After the injection of the contrast agent, sonogram shows the focal thickened endometrium
• Indications – Gynecological diseases such as ovarian tumors,
uterine myoma, adenomyosis, endometrial cancer, and residual in the uterine cavity.
– It can be used to understand the blood supply of
lesions.
• Preoperative preparation – Transvaginal probe with the frequency of
5~7.5MHz or transabdominal with the frequency of 3.5MHz.
– Contrast agent: SonoVue contrast agent produced
by Italian Bracco company, each contrast agent contains hexauoride Sulfur (SF6) gas encapsulat­ing 59 mg of phospholipid. Before usage, mix with 5 ml of normal saline and shake to extract
4.8ml of white milky microbubble suspension.
310
ab
H. Luo et al.
Fig. 7.21 Sonohysterography of the incomplete uterus septum. (a) The patient is 30years old, and uterus septum is suspected by ultra­sound examination; (b) After injection of contrast agent, the left uterine
a
c
cavity is separated by 0.7cm, and the right uterine cavity is divided by
0.8cm. No specic occupation is found in the uterine cavity on both sides. The width of the septum is about 1.0cm
b
Fig. 7.22 Sonohysterography of complete uterus septum. (a) The patient is 26years old, and uterus septum is suspected. (b) After injec­tion of contrast agent, two uterine cavities separate from the cervix to
the fundus of the uterus. (c) After injection of contrast agent, the septum is approximately 0.6cm in width and about 3.2cm long
ab
7 Interventional Ultrasound inObstetrics andGynecology
311
Fig. 7.23 Sonohysterography of intrauterine residues (I). (a) The patient is 26 years old and had a miscarriage 2 months ago. Ultrasonography shows a slightly hyperechoic mass with a diameter of about 2.0 cm, located in the right uterine corner; (b) After injection of
contrast agent, a slightly hyperechoic mass of 2.1 cm × 0.9 cm × 1.8 cm is visible at the right corner of the uterine cavity, with irregular shape and oating in the contrast agent
ab
Fig. 7.24 Sonohysterography of intrauterine residues (II). (a) The patient is 26years old and developed amenorrhea after a miscarriage 2months ago. The ultrasonography shows the posterior uterus, and the hypoechoic mass in the uterine cavity; (b) After injection of contrast
agent, sono gram shows a slightly hypoechoic mass of 2.1 cm × 1.8 cm × 2.2 cm on the left side of the uterine cavity. The mass is irregular and inhomoge neous, with surrounding irregular echoless area (contrast agent)
a b
Fig. 7.25 Sonohysterography of incarcerated IUD. (a) The patient is 46years old and failed to take the IUD out of the uterine cavity for 2 months. (b) Sonohysterography shows part of the IUD is embedded into the myometrium
312
ab
ab
ab
H. Luo et al.
Fig. 7.26 Sonohysterography of intrauterine adhesions. (a) The patient is 28years old and has amenorrhea for three months after the abortion. Before the sonohysterography, ultrasound examination shows that a dark area of 2.1cm×2.5cm×1.4cm in the uterine cavity; (b)
Fig. 7.27 Salpingography of the patent fallopian tube (positive contrast agent). (a) The contrast agent is around the ovary in the pelvis; (b) Three- dimensional ultrasound shows that the fallopian tubes are unobstructed
After dilating the cervical ostium, about 3ml of old hemorrhage ows out. After injection of the contrast agent, the uterine cavity is separated by 1.5cm, and the hyperechoic adhesion of about 1cm is found in the uterus
Fig. 7.28 Salpingography of the obstructed fallopian tube (positive contrast agent). (a) There is almost no diffusion of contrast agent in the pelvic cavity; (b) 3-D ultrasound shows the obstructed proximal end of the fallopian tube
7 Interventional Ultrasound inObstetrics andGynecology
Fig. 7.29 Salpingography of the partially obstructed fallopian tube (positive contrast agent). 3-D ultrasonography shows the partially obstructed right fallopian tube, and the left fallopian tube hydrops
313
• Operative process (taking ovarian tumor as an
example)
CEUS can be taken in two ways: transabdominal
and transvaginal.
– Routine ultrasound examination
Transabdominal and transvaginal ultrasonogra­phy is applied to observe uterus, adnexa, and pel­vic cavity in multiple views to detect the lesion, as well as observe the location, shape, size, nature, boundary, and the internal echo. Color Doppler is used to observing the blood ow condition. Do not forget to store the images.
– CEUS examination
2.4ml of Sonovue microbubble suspension was injected into the left elbow vein within 3s, and then a bolus of normal saline was injected. The
a
b
F
UT
c
Fig. 7.30 Patency of fallopian tube (negative contrast agent). (a) After the injection of the contrast agent, the hyperechoic owing column of water is visible around the adnexa, indicating that the patient’s fallopian tube is unobstructed. (b) After the salpingography, there is a free
anechoic area in the rectouterine pouch, indirectly indicating that the patient’s fallopian tube is unobstructed. (c) Hysterosalpingography shows that the patient’s bilateral fallopian tubes are unobstructed
314
ab
cd
H. Luo et al.
a b
Fig. 7.31 Hysterosalpingography of hydrosalpinx. (a) When the contrast medium is injected, there are moving dot echoes in the dilated fallopian tube; (b) Hysterosalpingography shows hydrosalpinx
Fig. 7.32 Sonogram of ultrasound monitoring during intrauterine sur­gery. (a) Before the surgery, the sagittal view of the uterus. (b) Before the surgery, the transverse section of the uterus. (c) During the surgery, in the sagittal view of the uterus, there are hyperechoic bands, followed
by “comet tail sign” in the uterine cavity. (d) During the surgery, in the transverse section, there is a strong spotty echo in the uterine cavity, followed by “comet tail sign”